More than 2,000 immune-oncology drugs now in development
admin 8th December 2017 Uncategorised 0Could lead to “unparalleled” advances in the field More: More than 2,000 immune-oncology drugs now in development Source: News
read moreCould lead to “unparalleled” advances in the field More: More than 2,000 immune-oncology drugs now in development Source: News
read moreMore results may be out from a closely watched trial of Roche’s Tecentriq in lung cancer, but industry watchers still don’t have many of the answers they’re looking for. More: Roche's latest Tecentriq results shed little light on the lung
read more© 1994 - 2026 B.M. Pharmaceuticals